PolyPeptide Group TO PRESENT CASE STUDY & SYMPOSIUM LECTURES AT TIDES®
TORRANCE, CA, USA, March 31, 2005 – PolyPeptide Group, a leading manufacturer of active pharmaceutical ingredients based on peptides, will be presenting symposium lectures and a case study at the TIDES meeting in Boston, MA, May 1-6, 2005. PolyPeptide Group, a regular sponsor of TIDES, will be exhibiting at the meeting.
Michael Verlander, D. Phil, Executive Vice President, PolyPeptide Group, Inc., will present "From IND to NDA: The Challenges of Meeting CMC Requirements for Peptides" at Symposium #1 on Sunday, May 1. A member of the Scientific Advisory Committee for TIDES, Dr. Verlander will also be part of the "Ask the Experts" session on Wednesday, May 4. On Thursday, May 5, Birgitta Mornstam, M.Sc., Manager, Qualification & Validation Europe, PolyPeptide Group AB, will present the case study, "An Approach for Successful Process Validation." Examples from experience with the validation of manufacturing processes for peptide APIs will be reported.
Since its inception, TIDES has been "the meeting" for pharmaceutical and biotech companies developing peptide drugs to meet and discuss their projects. "It gives us great pleasure to be invited to speak at TIDES. Peptide therapeutics are enjoying a renaissance and we expect the number of approved peptide-based drugs to grow rapidly over the next few years. This meeting is particularly important for companies that are developing peptide APIs for the first time. It brings them into contact with experts from all fields of peptide manufacturing, including companies such as our own that have a strong track record of peptide-based drug substance approvals," said Jane Salik, President, PolyPeptide Group. "We are pleased to act as sponsors, organizers, exhibitors, and presenting lecturers at TIDES."
PolyPeptide Group is a leading international, privately owned group of companies focused exclusively on the manufacture of active pharmaceutical ingredients based on peptides. PolyPeptide Group manufactures both proprietary and generic peptides for the pharmaceutical industry.
If you will be attending the show and would like to set up an appointment with PolyPeptide Group, please call +1-310-782-3569 or 800-770-0557 (toll-free within the US).
PolyPeptide Laboratories A/S